[ORGANIZATION]
CRISPR Therapeutics
Featured in 5 tracked stories · first seen
Situations
Gene-editing technology clinical progress and risks
6 clusters · 18 sources · last updated
Latest: Embryo gene editing research advances with new base editing studies
Advancements in gene-editing technologies, including CRISPR-Cas9, base editing, and prime editing, are demonstrating significant therapeutic potential. Research from the Broad Institute indicates these tools are being ut
Also covered in
-
Vertex Pharmaceuticals expands pipeline beyond cystic fibrosis
[BUSINESS] · 2 sources ·
-
Archer Aviation and CRISPR Therapeutics Highlighted as Top Mid‑Cap Growth Picks
[BUSINESS] · 2 sources ·